Veru Inc (NASDAQ:VERU) Director Harry Fisch purchased 10,000 shares of the business’s stock in a transaction on Monday, March 12th. The stock was acquired at an average price of $1.80 per share, with a total value of $18,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Harry Fisch also recently made the following trade(s):
- On Friday, March 9th, Harry Fisch purchased 10,000 shares of Veru stock. The stock was acquired at an average price of $1.88 per share, with a total value of $18,800.00.
- On Wednesday, March 7th, Harry Fisch purchased 24,000 shares of Veru stock. The stock was acquired at an average price of $1.62 per share, with a total value of $38,880.00.
Shares of Veru Inc (NASDAQ:VERU) traded down $0.06 on Monday, reaching $1.76. The company’s stock had a trading volume of 178,202 shares, compared to its average volume of 108,396. The firm has a market cap of $97.39, a P/E ratio of -6.52 and a beta of 0.96. Veru Inc has a 52 week low of $0.90 and a 52 week high of $3.00.
Several research analysts have weighed in on the company. HC Wainwright set a $5.00 price target on Veru and gave the company a “buy” rating in a report on Thursday, December 14th. ValuEngine downgraded Veru from a “hold” rating to a “sell” rating in a report on Friday, November 17th. Finally, Zacks Investment Research downgraded Veru from a “hold” rating to a “strong sell” rating in a report on Saturday, January 6th.
TRADEMARK VIOLATION WARNING: “Veru Inc (VERU) Director Harry Fisch Purchases 10,000 Shares” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/03/12/veru-inc-veru-director-harry-fisch-purchases-10000-shares.html.
Veru Inc, formerly The Female Health Company, is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector.
Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with MarketBeat.com's FREE daily email newsletter.